Gastric cancer in Asia: Progress and controversies in surgical management

被引:5
作者
Branicki, FJ [1 ]
Chu, KM [1 ]
机构
[1] Univ Hong Kong, Dept Surg, Queen Mary Hosp, Hong Kong, Hong Kong
来源
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY | 1998年 / 68卷 / 03期
关键词
D O I
10.1111/j.1445-2197.1998.tb04739.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Considerable controversy surrounds the management of gastric cancer and this has largely overshadowed recent progress in our understanding of the epidemiology and molecular pathogenesis of the disease, and improvements in diagnostic and staging techniques. Differences identifiable in the molecular pathogenesis of the 'intestinal' and 'diffuse' types of gastric cancer may help to unravel the biological behaviour of variants and ultimately influence therapeutic strategies. Endoscopic ultrasound is well established as being accurate for T staging and the introduction of laparoscopy, with or without ultrasound, is obviating unnecessary laparotomy in nonbleeding, non-obstructed patients. Controversies in surgery encompass the role of laparoscopic surgery in early gastric cancer, the extent of lymphadenectomy including para-aortic nodal dissection, resection of en bloc contiguous organ involvement, pancreatosplenectomy, left upper abdominal evisceration, and modes of reconstruction (pylorus-preserving gastrectomy, pouch formation) to enhance quality of life. Whereas adjuvant chemotherapy does not impact favourably on survival, emphasis has now shifted to neoadjuvant (induction) chemotherapy to downstage the disease. Preoperative regional chemotherapy and intra-operative hyperthermic chemotherapy or irradiation may prove to be of benefit in patients with resectable disease, but some scepticism still exists as to the usefulness of biological response modifiers (e.g. OK432, PSK) for adjuvant treatment. Ethical issues relating to cultural differences in Asia sometimes mitigate against adequate trial design (e.g. a surgery-alone control group or a no adjuvant therapy treatment group may be considered inappropriate) and this has understandably hindered acceptance in Western countries of the value of current management practices in Asia. These issues and the need for ongoing well-conducted randomized trials with prospective subset analysis are now being addressed.
引用
收藏
页码:172 / 179
页数:8
相关论文
共 105 条
[1]  
ABE M, 1995, WORLD J SURG, V194, P554
[2]   MACROSCOPICALLY NODE-NEGATIVE BUT HISTOLOGICALLY NODE-POSITIVE GASTRIC-CARCINOMA [J].
ADACHI, Y ;
MORI, M ;
MAEHARA, Y ;
SUGIMACHI, K .
BRITISH JOURNAL OF SURGERY, 1995, 82 (09) :1254-1256
[3]  
AJANI JA, 1991, CANCER-AM CANCER SOC, V68, P1501, DOI 10.1002/1097-0142(19911001)68:7<1501::AID-CNCR2820680706>3.0.CO
[4]  
2-L
[5]   Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer [J].
Averbach, AM ;
Jacquet, P .
BRITISH JOURNAL OF SURGERY, 1996, 83 (06) :726-733
[6]  
BENTHIN F, 1993, REG CANC TREAT S1, V6, P6
[7]   COMPARISON OF FACTORS INFLUENCING THE PROGNOSIS OF JAPANESE, GERMAN, AND DUTCH GASTRIC-CANCER PATIENTS [J].
BONENKAMP, JJ ;
VANDEVELDE, CJH ;
KAMPSCHOER, GHM ;
HERMANS, J ;
HERMANEK, P ;
BEMELMANS, M ;
GOUMA, DJ ;
SASAKO, M ;
MARUYAMA, K .
WORLD JOURNAL OF SURGERY, 1993, 17 (03) :410-415
[8]   LYMPH-NODE DISSECTION IN GASTRIC-CANCER [J].
BONENKAMP, JJ ;
VANDEVELDE, CJH .
BRITISH JOURNAL OF SURGERY, 1995, 82 (07) :867-869
[9]   SURGICAL PATHOLOGICAL-STAGE MIGRATION CONFOUNDS COMPARISONS OF GASTRIC-CANCER SURVIVAL RATES BETWEEN JAPAN AND WESTERN COUNTRIES [J].
BUNT, AMG ;
HERMANS, J ;
SMIT, VTHBM ;
VANDEVELDE, CJH ;
FLEUREN, GJ ;
BRUIJN, JA .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :19-25
[10]   GASTRIC-CARCINOMA WITH SYNCHRONOUS LIVER METASTASES - PALLIATIVE GASTRECTOMY OR NOT [J].
CHOW, LWC ;
LIM, BH ;
LEUNG, SYL ;
BRANICKI, FJ ;
GERTSCH, P .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1995, 65 (10) :719-723